Ruxolitinib attenuates cardio-renal inflammation via JAK-STAT and CaMKII signaling in hypertension

13 June 2026 (12:14 - 12:17)

Organised by:

Video

Sign in for access options

About the speaker

Ms Mara Luisa Kiessling

Medical University of Graz, Graz (Austria)

9 More presentations in this session

Presentation thumbnail

Investigating oxpl-mediated vascular inflammation in humanized Lp(a) transgenic mice: a preclinical study toward novel therapeutic strategies

Mr V. Antoniou (Athens, GR)

Presentation thumbnail

Variant-specific drug responses in FH: an ex vivo pilot study

Mr R. Graca (Lisbon, PT)

Presentation thumbnail

Transcriptomic analysis of mRNA in mouse model of chronic cigarette smoke-induced endothelial dysfunction treated with recombinant angiotensin-converting enzyme 2

Mr H. Hermawan (Surabaya, ID)

Presentation thumbnail

Role and mechanisms of the J1 gene in pulmonary arterial hypertension

Miss J. Ma (Guangzhou, CN)

Presentation thumbnail

Unexpected cardioprotection in doxorubicin-treated mice during sepsis: Dennd4a-Rab10 axis as a potential mediator

Miss K. Markandran (Singapore, SG)

Access the full session

Session thumbnail

Module B: Mentoring & how-to sessions - Poster rapid fire session 4

The Event

Event poster

Basic Science Course 2026

13 June 2026 12:14 CET

You may be interested in

Congress Session

Cardiovascular burden of kidney dysfunction: vascular phenotype, risk, and long-term outcomes

30 August 2026

Seminar Presentation

Immunity and vascular diseases

11 June 2026

Congress Session

New therapeutic approaches for heart failure

22 May 2022

Congress Session

Hot papers in hypertension 2023/2024

1 September 2024

ESC 365 is supported by

Lilly

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

Lilly

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources